A data science roadmap for open science organizations engaged in early-stage drug discovery

The Structural Genomics Consortium is an international open science research organization with a focus on accelerating early-stage drug discovery, namely hit discovery and optimization. We, as many others, believe that artificial intelligence (AI) is poised to be a main accelerator in the field. The...

Full description

Bibliographic Details
Main Authors:	Edfeldt, K, Edwards, AM, Engkvist, O, Günther, J, Hartley, M, Hulcoop, DG, Leach, AR, Marsden, BD, Menge, A, Misquitta, L, Müller, S, Owen, DR, Schütt, KT, Skelton, N, Steffen, A, Tropsha, A, Vernet, E, Wang, Y, Wellnitz, J, Willson, TM, Clevert, D, Haibe-Kains, B, Schiavone, LH, Schapira, M
Format:	Journal article
Language:	English
Published:	Nature Research 2024

A data science roadmap for open science organizations engaged in early-stage drug discovery

Similar Items